Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...

Approval is Another Milestone of Viatris' Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy ...

US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...

Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...

Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...

Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...

Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD: Rancho Cucamonga, California Tuesday, August 12, 2025, ...

Genshin Impact 6.0 leaks suggest the Nod-Krai region will introduce a unique resonance buff, boosting Lunar Reaction damage ...

Among Indian generics makers, Iron Sucrose had been considered a key pipeline product for Dr. Reddy’s Laboratories and ...

Building on their success developing a cleaner way to make valuable organic acids, researchers from the Center for Advanced ...

Shares of medication company Viatris (NASDAQ:VTRS) jumped 3% in the morning session after it received approval from the U.S.

Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.